ClinicalTrials.gov
ClinicalTrials.gov Menu

Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo During Implementation of Stages 1 and 2 (EBOVAC-Salone)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02509494
Recruitment Status : Active, not recruiting
First Posted : July 28, 2015
Last Update Posted : August 16, 2018
Sponsor:
Collaborators:
London School of Hygiene and Tropical Medicine
Ministry of Health and Sanitation of Sierra Leone
College of Medicine and Allied Health Sciences (COMAHS)
University of Oxford
Institut National de la Santé Et de la Recherche Médicale, France
Grameen Foundation
World Vision of Ireland
Information provided by (Responsible Party):
Janssen Vaccines & Prevention B.V.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : August 2, 2019
  Estimated Study Completion Date : August 2, 2019